ASC-J9 Size:Solid 10 mg BRN 0292084

BRN 0292084

2008 Jul 10

1438492-26-2

Smiles: C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@@H](CO)O[C@H]2O[C@@]23C[C@]4(CC2=C)CC[C@@H]2[C@@](C)(CCC[C@@]2(C)[C@@H]4CC3)C(=O)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O

and insulin more potently

ASC-J9 Size:Solid 10 mg BRN 0292084ASC J9, also known as GO Y025 and Dimethylcurcumin, is an AR degradation enhancer ASC J9 suppresses castration resistant prostate cancer growth through degradation of full length and splice variant androgen receptors. ASC J9 suppresses renal cell carcinoma progression by targeting an androgen receptor dependent HIF2 VEGF signaling pathway. ASC J9 treatment enhanced BCG efficacy to suppress bladder cancer cell proliferation via increasing the